The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial-Reference-Cited by-同舟云学术

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

Published:2011-08-02 Issue:3 Volume:2 Page:153-161
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J Cachexia Sarcopenia Muscle

Author:

Dalton James T.¹,Barnette Kester G.¹,Bohl Casey E.¹,Hancock Michael L.¹,Rodriguez Domingo¹,Dodson Shontelle T.¹,Morton Ronald A.¹,Steiner Mitchell S.¹

Affiliation:

1. GTx, Inc.; 175 Toyota Plaza 38103 Memphis TN

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s13539-011-0034-6

Reference42 articles.

1. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia;Argiles;Int J Biochem Cell Biol,2005

2. Management of muscle wasting in cancer-associated cachexia;Baracos;Cancer,2001

3. Sarcopenia and its implications for the elderly;Roubenoff;Eur J Clin Nutr,2000